minimal Common Oncology Data Elements (mCODE) Implementation Guide, published by HL7 International / Clinical Interoperability Council. This guide is not an authorized publication; it is the continuous build for version 4.0.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/fhir-mCODE-ig/ and changes regularly. See the Directory of published versions
: cancer-related-medication-admin-doxorubicin-jenny-m - TTL Representation
Raw ttl | Download
@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix sct: <http://snomed.info/id/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
# - resource -------------------------------------------------------------------
a fhir:MedicationAdministration ;
fhir:nodeRole fhir:treeRoot ;
fhir:id [ fhir:v "cancer-related-medication-admin-doxorubicin-jenny-m"] ; #
fhir:meta [
( fhir:profile [
fhir:v "http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-cancer-related-medication-administration"^^xsd:anyURI ;
fhir:link <http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-cancer-related-medication-administration> ] )
] ; #
fhir:text [
fhir:status [ fhir:v "extensions" ] ;
fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: MedicationAdministration cancer-related-medication-admin-doxorubicin-jenny-m</b></p><a name=\"cancer-related-medication-admin-doxorubicin-jenny-m\"> </a><a name=\"hccancer-related-medication-admin-doxorubicin-jenny-m\"> </a><a name=\"cancer-related-medication-admin-doxorubicin-jenny-m-en-US\"> </a><p><b>Normalization Basis Extension</b>: <span title=\"Codes:{http://snomed.info/sct 363804004}\">Body weight characteristic (observable entity)</span></p><p><b>status</b>: Completed</p><p><b>category</b>: <span title=\"Codes:{http://terminology.hl7.org/CodeSystem/medicationrequest-category outpatient}\">Outpatient</span></p><p><b>medication</b>: <span title=\"Codes:{http://www.nlm.nih.gov/research/umls/rxnorm 1790099}\">10 ML doxorubicin hydrochloride 2 MG/ML Injection</span></p><p><b>subject</b>: <a href=\"Patient-cancer-patient-jenny-m.html\">Jenny M Female, DoB: 1965-01-01 ( Medical Record Number: MRN1234 (use: usual, ))</a></p><p><b>effective</b>: 2018-04-22</p><h3>Performers</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Actor</b></td></tr><tr><td style=\"display: none\">*</td><td><a href=\"Practitioner-us-core-practitioner-nancy-oncology-nurse.html\">Practitioner Nancy Nurse </a></td></tr></table><p><b>reasonReference</b>: <a href=\"Condition-primary-cancer-condition-jenny-m.html\">Condition Primary malignant neoplasm of female left breast (disorder)</a></p><p><b>request</b>: <a href=\"MedicationRequest-cancer-related-medication-request-doxorubicin-jenny-m.html\">MedicationRequest: extension = Curative - procedure intent (qualifier value); status = active; intent = order; category = Outpatient; medication[x] = DOXOrubicin; authoredOn = 2018-04-12</a></p><p><b>note</b>: doxorubicin (60 mg/m² IV), 105.96 mg in 50 ml 0.9% normal saline administered by continuous infusion. Patient tolerated infusion without side effects. (By Practitioner/us-core-practitioner-nancy-oncology-nurse @2018-04-22)</p><h3>Dosages</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Route</b></td><td><b>Dose</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{http://snomed.info/sct 47625008}\">Intravenous route (qualifier value)</span></td><td>105.96 mg<span style=\"background: LightGoldenRodYellow\"> (Details: UCUM codemg = 'mg')</span></td></tr></table></div>"
] ; #
fhir:extension ( [
fhir:url [ fhir:v "http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-normalization-basis"^^xsd:anyURI ] ;
fhir:value [
a fhir:CodeableConcept ;
( fhir:coding [
a sct:363804004 ;
fhir:system [ fhir:v "http://snomed.info/sct"^^xsd:anyURI ] ;
fhir:code [ fhir:v "363804004" ] ;
fhir:display [ fhir:v "Body weight characteristic (observable entity)" ] ] ) ]
] ) ; #
fhir:status [ fhir:v "completed"] ; #
fhir:category [
( fhir:coding [
fhir:system [ fhir:v "http://terminology.hl7.org/CodeSystem/medicationrequest-category"^^xsd:anyURI ] ;
fhir:code [ fhir:v "outpatient" ] ] )
] ; #
fhir:medication [
a fhir:CodeableConcept ;
( fhir:coding [
fhir:system [ fhir:v "http://www.nlm.nih.gov/research/umls/rxnorm"^^xsd:anyURI ] ;
fhir:code [ fhir:v "1790099" ] ;
fhir:display [ fhir:v "10 ML doxorubicin hydrochloride 2 MG/ML Injection" ] ] )
] ; #
fhir:subject [
fhir:reference [ fhir:v "Patient/cancer-patient-jenny-m" ]
] ; #
fhir:effective [ fhir:v "2018-04-22"^^xsd:date] ; #
fhir:performer ( [
fhir:actor [
fhir:reference [ fhir:v "Practitioner/us-core-practitioner-nancy-oncology-nurse" ] ]
] ) ; #
fhir:reasonReference ( [
fhir:reference [ fhir:v "Condition/primary-cancer-condition-jenny-m" ]
] ) ; #
fhir:request [
fhir:reference [ fhir:v "MedicationRequest/cancer-related-medication-request-doxorubicin-jenny-m" ]
] ; #
fhir:note ( [
fhir:author [
a fhir:Reference ;
fhir:reference [ fhir:v "Practitioner/us-core-practitioner-nancy-oncology-nurse" ] ] ;
fhir:time [ fhir:v "2018-04-22"^^xsd:date ] ;
fhir:text [ fhir:v "doxorubicin (60 mg/m² IV), 105.96 mg in 50 ml 0.9% normal saline administered by continuous infusion. Patient tolerated infusion without side effects." ]
] ) ; #
fhir:dosage [
fhir:route [
( fhir:coding [
a sct:47625008 ;
fhir:system [ fhir:v "http://snomed.info/sct"^^xsd:anyURI ] ;
fhir:code [ fhir:v "47625008" ] ;
fhir:display [ fhir:v "Intravenous route (qualifier value)" ] ] ) ] ;
fhir:dose [
fhir:value [ fhir:v "105.96"^^xsd:decimal ] ;
fhir:unit [ fhir:v "mg" ] ;
fhir:system [ fhir:v "http://unitsofmeasure.org"^^xsd:anyURI ] ;
fhir:code [ fhir:v "mg" ] ]
] . #
|
Propose a change